Axsome Therapeutics, Inc. (1AXSM)
MTA
Closed
Aug 24, 2026
Day's Range
184.7552 wk Range
104.10Overview - 1AXSM - Axsome Therapeutics, Inc.
Key Statistics
Valuation
Enterprise Value
7.95B
P/E (Trailing)
‪-50.20‬
PEG Ratio
‪-15.31‬
Price / Sales (TTM)
‪12.10‬
Price / Book
‪131.67‬
EV / EBITDA
‪-53.82‬
Profitability
Gross Margin
‪92.29%‬
Profit Margin
‪-24.67%‬
Operating Margin
‪-23.41%‬
Return on Assets
‪-16.31%‬
Return on Equity
‪-245.10%‬
Ownership
Shares Outstanding
51.42M
Float
44.46M
Held by Insiders
‪15.08%‬
Held by Institutions
‪74.57%‬
Price stats
Beta
‪0.72‬
50-Day Avg
‪203.07‬
200-Day Avg
‪165.61‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 1AXSM - Axsome Therapeutics, Inc.
Peers - 1AXSM - Axsome Therapeutics, Inc.
Peer Comparison
Compared with companies in Biotechnology listed on MTA.
- 1AXSMMTAAxsome Therapeutics, Inc.8.19BMarket Cap+43.65%52-week change-50.20P/E (Trailing)‪-24.67%‬Profit Margin
- 1VRTXMTAVertex Pharmaceuticals Incorporated107.27BMarket Cap+27.82%52-week change32.13P/E (Trailing)‪34.99%‬Profit Margin
- 1REGNMTARegeneron Pharmaceuticals Inc.73.52BMarket Cap+27.69%52-week change20.61P/E (Trailing)‪27.86%‬Profit Margin
- 1ALNYMTAAlnylam Pharmaceuticals Inc45.81BMarket Cap-89.61%52-week change41.96P/E (Trailing)‪16.12%‬Profit Margin
- 1ALABMTAASTERA LABS INC COMMON STOCK (Ticker: 1ALAB)41.80BMarket Cap+47.15%52-week change137.71P/E (Trailing)‪30.74%‬Profit Margin
- 1INSMMTAInsmed Inc30.28BMarket Cap+16.20%52-week change-17.19P/E (Trailing)‪-76.94%‬Profit Margin
- 1CGMTAThe Carlyle Group Inc.18.64BMarket Cap-16.74%52-week change50.83P/E (Trailing)‪13.01%‬Profit Margin
Profile Summary - 1AXSM - Axsome Therapeutics, Inc.
About
Axsome Therapeutics is a commercial-stage biopharmaceutical company specializing in the development and commercialization of small-molecule medicines and novel therapies targeting central nervous system disorders. The company focuses on conditions with limited treatment options, including depression, Alzheimer's…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
